FDA Slows New Drug Approval

The Food and Drug Administration has slowed dramatically in the last year of Obama’s Presidency, The Washington Examiner reports.

“Drug approvals in 2016 were down sharply from the year before and were the lowest in six years.

The Food and Drug Administration gave the nod to just 22 new medications, after approving 45 new drugs in 2015. Approvals were at their lowest since 2010.

FDA officials say approvals fell because of several factors, including a half dozen drugs that were originally scheduled for approval in early 2016 but got the go-ahead at the end of 2015. In addition, fewer drugmakers filed products for approval and the FDA rejected or delayed more applications than in previous years.”